{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:49:40Z","timestamp":1791859780129,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006209","name":"CNPq","doi-asserted-by":"publisher","award":["307735\/2012-5"],"award-info":[{"award-number":["307735\/2012-5"]}],"id":[{"id":"10.13039\/100006209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002753","name":"REUNI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.pnpbp.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T06:30:36Z","timestamp":1393655436000},"page":"35-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["PPAR-\u03b1 agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease"],"prefix":"10.1016","volume":"53","author":[{"given":"Jana\u00edna K.","family":"Barbiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronise","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda S.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suelen","family":"Boschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa Mota","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda","family":"de Paula Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.B.F.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2014.02.009_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease \u2014 epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1975.00490440064010","article-title":"Brain peroxidase and catalase in Parkinson disease","volume":"32","author":"Ambani","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0020","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2010.07.033","article-title":"Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease","volume":"216","author":"Barbiero","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0030","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cortex.2008.11.010","article-title":"Parkinson's disease: the syndrome, the pathogenesis and pathophysiology","volume":"45","author":"Bartels","year":"2009","journal-title":"Cortex"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0035","first-page":"463","article-title":"The effect of peroxisome proliferator-activated receptors \u03b1 (PPAR\u03b1) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity","volume":"53","author":"Beltowski","year":"2002","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(02)01174-7","article-title":"Glutathione, iron and Parkinson's disease","volume":"64","author":"Bharath","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2011.10.029","article-title":"Peroxisome proliferator-activated receptor-\u03b1 activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms","volume":"674","author":"Bhateja","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0341341","article-title":"PPAR: a new pharmacological target for neuroprotection in stroke and neuro-degenerative diseases","volume":"34","author":"Bordet","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/658520","article-title":"PPAR regulation of inflammatory signaling in CNS diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0079-6123(10)84002-6","article-title":"Neurotoxic in vivo models of Parkinson's disease: recent advances","volume":"184","author":"Cannon","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2008.07.022","article-title":"Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats","volume":"594","author":"Capitelli","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0070","first-page":"112","article-title":"Modulating microglia activity with PPAR-\u04af, agonists: a promising therapy for Parkinson's disease?","volume":"2","author":"Carta","year":"2012","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.nut.2007.05.004","article-title":"Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice","volume":"23","author":"Chen","year":"2007","journal-title":"Nutrition"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0080","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/neu.2006.0216","article-title":"Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury","volume":"24","author":"Chen","year":"2007","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2006.04.030","article-title":"Oxidative stress and inflammatory response evoked by transient cerebral ischemia\/reperfusion: effects of the PPAR-\u03b1 agonist WY14643","volume":"41","author":"Collino","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pnpbp.2013.05.002","article-title":"A proposal for refining the forced swim test in Swiss mice","volume":"45","author":"Costa","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0095","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0115","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0105","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxysome proliferator-activated receptor alpha negatively regulates the inflammatory gene response by negative cross-talk with transcription factors NF-kB and AP-1","volume":"274","author":"Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0110","doi-asserted-by":"crossref","first-page":"36703","DOI":"10.1074\/jbc.M004045200","article-title":"Induction of IkB\u03b1 expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators","volume":"275","author":"Delerive","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0125","first-page":"36703","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"275","author":"Dexter","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yjmcc.2003.11.004","article-title":"PPARa activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats","volume":"36","author":"Diep","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2010.11.013","article-title":"Statins \u2014 increasing or reducing the risk of Parkinson's disease?","volume":"228","author":"Dolga","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/00207450108986511","article-title":"Effects of different ozone doses on memory, motor activity and lipid peroxidation levels, in rats","volume":"108","author":"Dorado-Martinez","year":"2001","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuint.2006.04.003","article-title":"Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders","volume":"49","author":"Drew","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02260967","article-title":"MPTP-induced behavioural and biochemical deficits: a parametric analysis","volume":"7","author":"Fredriksson","year":"1994","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0475","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0302-4598(98)00072-5","article-title":"Mechanism of pyrogallol autoxidation and determination of superoxide dismutase enzyme activity","volume":"45","author":"Gao","year":"1998","journal-title":"Bioelectrochem Bioenerg"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0160","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","article-title":"Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease","volume":"29","author":"Ghosh","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0896-6273(95)90287-2","article-title":"Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death","volume":"14","author":"Greenlund","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02741387","article-title":"Tyrosine hydroxylase and Parkinson's disease","volume":"16","author":"Haavik","year":"1998","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2131\/jts.35.41","article-title":"Neuroprotective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague\u2013Dawley rats","volume":"35","author":"Haleagrahara","year":"2010","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0175","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1016\/0197-0186(92)90256-Q","article-title":"The MPTP-treated mouse as a model of parkinsonism: how good is it?","volume":"20","author":"Heikkila","year":"1992","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2004.11.021","article-title":"Long-chain fatty acids increase cellular dopamine in an immortalized cell line (MN9D) derived from mouse mesencephalon","volume":"376","author":"Heller","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0185","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0190","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1128\/IAI.67.7.3488-3493.1999","article-title":"Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor","volume":"67","author":"Hill","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0739-7240(01)00117-5","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review","volume":"22","author":"Houseknecht","year":"2002","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00210-011-0660-8","article-title":"MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress","volume":"384","author":"Hsieh","year":"2011","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0460","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/157015907780077123","article-title":"Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson's disease","volume":"5","author":"Hunter","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/meta.2001.19415","article-title":"The ligands\/activators for peroxisome proliferators-activated receptor alpha (PPAR alpha) and PPAR gamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells","volume":"50","author":"Inoue","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0480","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0003-2697(92)90122-N","article-title":"Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein","volume":"202","author":"Jiang","year":"1992","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0215","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/00001756-199412000-00019","article-title":"Localization of the peroxisome proliferator-activated receptor in the brain","volume":"20","author":"Kainu","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0220","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1073\/pnas.90.6.2160","article-title":"Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers","volume":"90","author":"Keller","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0235","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0304-3940(85)90078-3","article-title":"Glutathione peroxidase activity in Parkinson's disease brain","volume":"58","author":"Kish","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2006.12.011","article-title":"Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not","volume":"1135","author":"Kreisler","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/FBP.0b013e32833a5c81","article-title":"Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease","volume":"21","author":"Kreisler","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2008.10.010","article-title":"Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease","volume":"197","author":"Kumar","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0245","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1096\/fj.03-0677fje","article-title":"Rotenone induces non-specific central nervous system and systemic toxicity","volume":"18","author":"Lapointe","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0250","first-page":"273","article-title":"The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review","volume":"71","author":"Leentjens","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","article-title":"Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats","volume":"1101","author":"Lima","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0260","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1460-9568.2008.06371.x","article-title":"Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice","volume":"28","author":"Litteljohn","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0265","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","article-title":"Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat","volume":"16","author":"Litteljohn","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2009.08.001","article-title":"The influence of microglia on the pathogenesis of Parkinson's disease","volume":"89","author":"Long-Smith","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0470","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"3","author":"Marklund","year":"1974","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0275","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1161\/01.CIR.99.24.3125","article-title":"PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells","volume":"99","author":"Marx","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0280","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1476-511X-9-122","article-title":"Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting","volume":"9","author":"Miyazaki","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2003","journal-title":"Neurosciences"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0295","first-page":"323","article-title":"Inhibition of NF-kappa B signaling by fenofibrate, a peroxisome pro-liferator activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis","volume":"23","author":"Okamoto","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0300","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/B:NEAB.0000009207.38914.2b","article-title":"Immunization of rats with conjugates of dopamine and serotonin with bovine serum albumin prevents the development of experimental MPTP-induced depressive syndrome (electrophysiological parameters)","volume":"34","author":"Pankova","year":"2004","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0305","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2003.11.029","article-title":"Behavioural and neurochemical effects os phosphatidylserine in MPTP lesion of the substantia nigra in rats","volume":"484","author":"Perry","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0315","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2005.05.009","article-title":"Intra-nigral MPTP lesion in rats: behavioral and autoradiography studies","volume":"195","author":"Perry","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0320","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","article-title":"Neurodegeneration and Inflammation in Parkinson's disease","volume":"1","author":"Phani","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0330","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioral despair in rats, a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/cimm.1999.1525","article-title":"Age-associated alterations in splenic iNOS regulation: influence of constitutively expressed IFN-gamma and correction following supplementation with PPAR alpha activators or vitamin E","volume":"195","author":"Poynter","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0335","first-page":"157","article-title":"Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"10","author":"Rajeswari","year":"2006","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0748233708093726","article-title":"Neuropathological changes induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in male Swiss albino mice","volume":"24","author":"Rajeswari","year":"2008","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0345","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","article-title":"The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats","volume":"560","author":"Reksidler","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0350","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-4328(02)00203-6","article-title":"In the rat forced swimming test, chronic but not subacute administration of dual 5-HT\/NA antidepressant treatments may produce greater effects than selective drugs","volume":"136","author":"Reneric","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0355","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/enrs.1999.3996","article-title":"Effects of taurine on ozone-induced memory deficits and lipid peroxidation levels in brains of young, mature, and old rats","volume":"82","author":"Rivas-Arancibia","year":"2000","journal-title":"Environ Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(98)00198-0","article-title":"Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice","volume":"245","author":"Rozas","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0375","first-page":"473","article-title":"The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice. an analysis of behavioral and biochemical variables","volume":"12","author":"Sankar","year":"2007","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0380","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0385","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","article-title":"Psychiatric aspects of Parkinson's disease \u2014 an update","volume":"251","author":"Schrag","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0485","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"1","author":"Sedlak","year":"1968","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0390","first-page":"48","article-title":"Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine","volume":"53","author":"Sharma","year":"2007","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0395","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pnpbp.2011.02.002","article-title":"Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications","volume":"35","author":"Solla","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0490","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.etp.2012.09.001","article-title":"Toxicity of MPTP on neurotransmission in three mouse models of Parkinson\u2019s disease","volume":"65","author":"St\u00e9phanie","year":"2013","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0410","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/gerona\/59.10.B997","article-title":"Modulation of PPAR in aging, inflammation and calorie restriction","volume":"59","author":"Sung","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0415","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0420","first-page":"2424","article-title":"Ligands for peroxisome proliferator activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats","volume":"61","author":"Tanaka","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0425","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1046\/j.1471-4159.1995.65062725.x","article-title":"Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain","volume":"65","author":"Thiffault","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0400","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0430","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyr-idine-lesioned mouse model of basal ganglia injury","volume":"32","author":"Vuckovic","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0435","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neures.2011.02.001","article-title":"Effects of chronic systemic treatment with peroxisome proliferator-activated receptor \u03b1 activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice","volume":"70","author":"Wang","year":"2011","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0440","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1096\/fj.01-0793com","article-title":"Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarction size","volume":"16","author":"Wayman","year":"2002","journal-title":"FASEB"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0445","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7861\/clinmedicine.13-1-93","article-title":"How to treat Parkinson's disease in 2013","volume":"13","author":"Worth","year":"2013","journal-title":"Clin Med"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0450","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-5-4","article-title":"Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K\/Akt","volume":"5","author":"Xing","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2014.02.009_bb0455","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneuroim.2009.10.016","article-title":"Peroxisome proliferator-activated receptor-\u04af, agonists suppress iNOS expression induced by LPS in rat primary Schwann cells","volume":"218","author":"Zhang","year":"2010","journal-title":"J Neuroimmunol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584614000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584614000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T18:37:22Z","timestamp":1597516642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584614000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":94,"alternative-id":["S0278584614000396"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2014.02.009","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR-\u03b1 agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2014.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}